MedPath

Cognitive Reserve and Second Language Acquisition

Not Applicable
Conditions
Executive Function
Interventions
Behavioral: Duolingo
Behavioral: Passive Control
Behavioral: BrainHQ
Registration Number
NCT03638882
Lead Sponsor
Rotman Research Institute at Baycrest
Brief Summary

Bilingualism has been shown to have a strong protective effect against dementia, delaying the diagnosis of Alzheimer's disease by up to 4 years. The purpose of the study is to test whether learning a second language using Duolingo software could improve cognitive functions in older adults.

Detailed Description

This study is a 3-arm, randomized controlled trial. The primary objective of the study is to test the impact of second language acquisition through short-term use of the Duolingo app on cognitive functioning, particularly executive function in older adults compared to a brain training application.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Participants must have normal vision and hearing.
  • Participants must be able to travel to Baycrest by personal or study-arranged automobile, or public transportation.
  • Participants must be monolingual native English speakers.
  • Participants must be willing to provide informed consent.
  • Participants must have daily access to a smartphone/mobile device.
  • Have not previously studied Spanish formally, nor any other language in the past 10 years.
Exclusion Criteria
  • have a neurological disorder.
  • meet DSM-IV-TR criteria for Axis I mood, anxiety, or psychotic or substance abuse disorders.
  • Fluent in more than one language.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Duolingo Spanish CourseDuolingo30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.
Passive ControlPassive ControlNo intervention.
BrainHQBrainHQ30 minutes each day, 5 days a week for 16 weeks. Total of 40 hours.
Primary Outcome Measures
NameTimeMethod
Change in inhibitory Control, DKEFSchange from baseline to 16 weeks

DKEFS Colour Word Interference

Change in inhibitory Control, Simon taskchange from baseline to 16 weeks

Inhibitory control assessed by the Simon task

Change in working memory, n-backchange from baseline to 16 weeks

Working memory assessed by the n-back test

Secondary Outcome Measures
NameTimeMethod
Change in attention abilitieschange from baseline to 16 weeks

Attention assessed by the Test of Everyday Attention (TEA)

Change in language abilitieschange from baseline to 16 weeks

Winterlight designed battery assessing paragraph reading and recall, picture description and object naming.

change in verbal fluencychange from baseline to 16 weeks

semantic and phonological fluency tasks

executive function assessed by trailmaking testchange from baseline to 16 weeks

Trails B implemented on tablet

Trial Locations

Locations (1)

Baycrest Health Sciences

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath